Stockreport

TRACON Pharmaceuticals Announces License of Product Development Platform for $3.0 Million Upfront Payment

TRACON PHARMS INC  (TCON) 
Last tracon pharms inc earnings: 2/27 04:03 pm Check Earnings Report
US:NASDAQ Investor Relations: traconpharma.com
PDF SAN DIEGO, Nov. 20, 2023 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals, Inc. (Nasdaq: TCON), a clinical stage biopharmaceutical company utilizing a cost-efficient, CRO-in [Read more]